Dr. David N. Potier
Education
| 2004-2008 | MChem (Hons) University of Manchester Manchester, UK |
| 2008-2012 | PhD University of Manchester Manchester, UK |
Present Appointment
| 2013- | Biochemist, Protein Analysis Team SGS M-Scan, Wokingham, Berkshire, UK |
Previous Appointment
| 2012-2013 | Research Associate Cardiovascular Division, King’s College London, London, UK |
| 2006-2007 | Analytical Scientist, Early Inhaled Development Department GlaxoSmithKline, Ware, Hertfordshire, UK |
Publications
| 1 | Barallobre-Barreiro J, Oklu R, Lynch M, Fava M, Baig F, Yin X, Barwari T, Potier D, Albadawi H, Jahangiri M, Porter K, Watkins M, Misra S, Stoughton J, Mayr M. Extracellular Matrix Remodeling in Response to Venous Hypertension: Proteomics of Human Varicose Veins. Cardiovasc Res. 2016 110 : 419-430. [Full Text] [PubMed] [DOI] |
| 2 | Potier DN, Griffiths JR, Unwin RD, Walker MJ, Carrick E, Willamson AJ, Whetton AD. An assessment of peptide enrichment methods employing mTRAQ quantification approaches. Anal Chem. 2012 84 : 5604-5610. [PubMed] [DOI] |
| 3 | Griaud F, Williamson AJ, Taylor S, Potier DN, Spooncer E, Pierce A, Whetton AD. BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response. J Proteomics. 2012 77 : 14-26. [PubMed] [DOI] |